Ixazomib for Treatment of Chronic Graft vs. Host Disease
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Ixazomib (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 12 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 06 Aug 2015 New trial record